Bird & Bird advises Bpifrance on its participation in ARTHEx Biotech’s $87M Series B upsized funding round

International law firm Bird & Bird advised Bpifrance, on its participation in ARTHEx Biotech’s $87 million expended Series B investment, a spin-off biotech company from the University of Valencia (Spain) focused on developing targeted RNA medicines for rare genetic neuromuscular disorders.

The series B extension financing was led by Bpifrance, as part of Large Venture and InnoBio investment strategies, and joined by existing shareholders, including AdBio Partners, CDTI Innovación, Columbus Venture Partners, European Innovation Council (EIC), Hadean Ventures, Invivo Partners and Sound Bioventures.

Proceeds from the financing will be used to further advance the global clinical development of ARTHEx’s lead program, ATX-01 for Myotonic Dystrophy Type 1 (DM1), including the ongoing interventional Phase I/IIa ArthemiRTM study and the preparation for an open-label extension to support a registrational study. This funding also aims to develop a broader range of targeted RNA-based medicines in areas of significant need, such as muscular, central nervous system and cardiac disorders.

The company has received Orphan Drug Designation for ATX-01 in DM1 from both US and European regulatory authorities, recognising the significant unmet medical need and the potential therapeutic benefit of this novel approach. Early patient data from clinical trials are expected in 2026.

Bird & Bird advised Bpifrance on the investment in ARTHEx Biotech with a cross-border team comprising partner Carole Bodin and associate Jasmine Javault from Paris office and partner Lourdes Ayala, counsel Antonio Ballesteros and associate Adrian Bert for Madrid office.

News & Deals

More News & Deals
Deal Bird & Bird advises Ciclad on acquiring a majority stake in Capelec Group

Oct 22 2025

Read More
News Bird & Bird Sponsors Slush for Fourth Consecutive Year

Oct 20 2025

Read More
Deal Bird & Bird advises FUJIFILM Healthcare on acquisition of endoscopy business

Oct 16 2025

Read More
Deal Bird & Bird advises Integrated Eduverse on Sale of SUN Education to StudyIn

Oct 16 2025

Read More
Deal Bird & Bird advises Obton A/S on financing the development costs of 72 photovoltaic farms in Poland

Oct 14 2025

Read More
Deal Bird & Bird advises Serwent on strategic acquisition of Röranalys i Sverige AB and ISAB Rörinfodring AB

Oct 10 2025

Read More